-+ 0.00%
-+ 0.00%
-+ 0.00%

Akebia Therapeutics Q3 Sales $58.766M Beat $58.235M Estimate

Benzinga·11/10/2025 12:04:01
Listen to the news
Akebia Therapeutics (NASDAQ:AKBA) reported quarterly sales of $58.766 million which beat the analyst consensus estimate of $58.235 million by 0.91 percent. This is a 57.01 percent increase over sales of $37.428 million the same period last year.